Heated Rivalry reaches 10.6 million viewers after massive post-finale surge
Heated Rivalry hits 10.6 million U.S. viewers as HBO Max reports huge audience growth after the finale release run

Heated Rivalry is continuing its impressive rise in popularity, drawing strong viewership numbers more than a month after the conclusion of its first season.
According to Warner Bros. Discovery (WBD), the series has now reached an average of 10.6 million viewers per episode in the United States, signaling its growing impact in the competitive streaming landscape.
Originally produced by Canadian streaming platform Crave, the drama streams on HBO Max in the U.S., where it quickly became a word-of-mouth success following its debut in November. The show demonstrated consistent momentum throughout its run, with each episode attracting a larger audience than the last.
The season finale, released on December 26, marked a major milestone for the series. WBD reports that finale viewership increased by more than 300% compared to the premiere week audience, highlighting the show’s expanding fan base and sustained engagement.
Even after the finale aired, interest in “Heated Rivalry” continued to climb. Warner Bros. Discovery states that the audience has more than doubled since the season wrapped, underscoring the series’ strong post-finale performance — a key indicator of long-term streaming success.
The company also confirmed that “Heated Rivalry” now ranks as the most-watched scripted title ever acquired from another platform in HBO Max history. The achievement reflects both the power of cross-platform distribution and the growing appetite for high-quality scripted dramas among streaming audiences.
With viewership still rising, “Heated Rivalry” appears poised to remain a standout title for HBO Max, further cementing its status as one of the breakout streaming hits of the season.


















COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ